Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perla R Colunga-Pedraza

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pediatric Blood & Cancer|June 15, 2011
Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?José Carlos Jaime-Pérez, Perla R Colunga-Pedraza, David Gómez-Almaguer
Acta Haematologica|September 19, 2018
Geographic Hematology: Some Observations in MexicoPerla R Colunga-Pedraza, Gisela B Gomez-Cruz, Julia E Colunga-Pedraza, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2022
Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitorFernando De la Garza-Salazar, Samantha P Peña-Lozano, David Gómez-Almaguer, et al.
Expert Review of Hematology|May 26, 2022
Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative reviewDavid Gómez-Almaguer, Edgar A Rojas-Guerrero, Andrés Gómez-De León, et al.
Therapeutic Advances in Hematology|March 3, 2022
Outpatient allogeneic hematopoietic stem-cell transplantation: a reviewDavid Gómez-Almaguer, Andrés Gómez-De León, Perla R Colunga-Pedraza, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 21, 2022
Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphomaRosalaura V Villarreal-González, Sandra N González-Díaz, Wendy J Santos-Fernández, et al.
Hematology (Amsterdam, Netherlands)|August 30, 2022
Diagnosis and treatment of acute lymphoblastic leukemia in Latin AmericaPerla R Colunga-Pedraza, Julia E Colunga-Pedraza, Samantha P Peña-Lozano, et al.
Blood Cells, Molecules & Diseases|July 24, 2012
Acute maternal cytomegalovirus infection is associated with significantly decreased numbers of CD34+ cells in umbilical cord bloodJosé C Jaime-Pérez, Julia E Colunga-Pedraza, Roberto Monreal-Robles, et al.
Pediatric Blood & Cancer|March 12, 2020
Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single-center Mexican experienceJulia E Colunga-Pedraza, Oscar González-Llano, Carlos Eugenio González-Martinez, et al.
JCO Global Oncology|April 28, 2021
Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to ActionAndrés Gómez-De León, Perla R Colunga-Pedraza, Luz Tarín-Arzaga, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|June 15, 2011
Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?José Carlos Jaime-Pérez, Perla R Colunga-Pedraza, David Gómez-Almaguer
Acta Haematologica|September 19, 2018
Geographic Hematology: Some Observations in MexicoPerla R Colunga-Pedraza, Gisela B Gomez-Cruz, Julia E Colunga-Pedraza, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2022
Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitorFernando De la Garza-Salazar, Samantha P Peña-Lozano, David Gómez-Almaguer, et al.
Expert Review of Hematology|May 26, 2022
Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative reviewDavid Gómez-Almaguer, Edgar A Rojas-Guerrero, Andrés Gómez-De León, et al.
Therapeutic Advances in Hematology|March 3, 2022
Outpatient allogeneic hematopoietic stem-cell transplantation: a reviewDavid Gómez-Almaguer, Andrés Gómez-De León, Perla R Colunga-Pedraza, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 21, 2022
Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphomaRosalaura V Villarreal-González, Sandra N González-Díaz, Wendy J Santos-Fernández, et al.
Hematology (Amsterdam, Netherlands)|August 30, 2022
Diagnosis and treatment of acute lymphoblastic leukemia in Latin AmericaPerla R Colunga-Pedraza, Julia E Colunga-Pedraza, Samantha P Peña-Lozano, et al.
Blood Cells, Molecules & Diseases|July 24, 2012
Acute maternal cytomegalovirus infection is associated with significantly decreased numbers of CD34+ cells in umbilical cord bloodJosé C Jaime-Pérez, Julia E Colunga-Pedraza, Roberto Monreal-Robles, et al.
Pediatric Blood & Cancer|March 12, 2020
Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single-center Mexican experienceJulia E Colunga-Pedraza, Oscar González-Llano, Carlos Eugenio González-Martinez, et al.
JCO Global Oncology|April 28, 2021
Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to ActionAndrés Gómez-De León, Perla R Colunga-Pedraza, Luz Tarín-Arzaga, et al.
Pageof 4